You are subscribed to the Formulary News Capsule. Unsubscribe here.

Formulary

Print Subscribe

Digital Edition Subscribe

December 21, 2012

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

Today's Headlines

Benzodiazepines risk

Benzodiazepines, which have been associated with an increased incidence of infections in the critically ill, also may increase the risk of community-acquired pneumonia and mortality following pneumonia, according to a recent report published in Thorax.
» Full article

Reduce disparities in hypertension

Making prescription refills more affordable and easier to get may reduce disparities among hypertension patients, according to a study online in Archives of Internal Medicine. » Full article

Compounding action plan

NABP Executive Director Carmen Catizone, MS, RPh, recently unveiled an action plan to inspect nonresident compounding pharmacies and create a database to share regulatory information about these pharmacies with the state boards of pharmacy nationwide. This was in response to the fungal meningitis outbreak that took the lives of 37 individuals and injured 590. » Full article

Reconsider financial aspect of adherence

Half of the 3.2 billion prescriptions dispensed annually are not taken as prescribed. Pharmacy benefit leaders must reconsider the financial context of medication adherence and medication possession, according to industry leaders presenting at a recent online seminar for the Pharmacy Benefit Management Institute
» Full article

ADVERTISEMENT

Comprehensive Drug Resource Helps You Save on Rx Cost: - Try Savings Calculator

Accessing all (both brand and generic) therapeutic drug alternatives provides the savings payers need, and improves member health. Learn more about how you can spend less on Rx benefits with MEDalternatives. Try cost savings calculator now.

CONTINUING EDUCATION

New CPE Series: December activity available now

Welcome to the fourth activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The December activity will cover insulin therapy for diabetes care management.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

EDITOR'S PICK

2012: A year of novel pharmalogic agents in review

In 2012, 10 newly approved or investigational drugs of interest to pharmacy and therapeutics (P&T) committee members have been the subject of Formulary's "Focus on" articles. The editors have compiled the following review of these agents, along with updates on the regulatory status of each. » Full article

 

Subscribe Now!

You must click here to continue receiving the Formulary News Capsule

Related Articles

Prevnar 13

Racial disparities in depression

FDA and compounding

Adherence and provider engagement

RESOURCES

Drug Watch

Latest Clinical News

SURVEY

In the midst of a major evolution in the healthcare industry, what is the most significant way in which formulary committee functions will need to evolve?

a) Greater focus on comparative effectiveness research as that data unfolds.

b) Broadened comparative review of both self-administered, as well as clinic/office-administered injectable therapies.

c) Enhanced incorporation of real-world safety and effectiveness data in review processes.

d) Modified formulary committee composition/review processes to reflect the deep pipeline of complex biologic therapies.

e) Greater demands placed upon industry to demonstrate superiority with new product introductions.


Respond here and see what your colleagues think too. Click here to see the results of our last survey.

What can Formulary do for you?

Take our super short survey TODAY! http://www.surveygizmo.com/s3/1050662/Formulary-Readers

 
Powered by Modern Medicine Advanstar Medical Communications Group